ABOUT GULSINE

THE SCIENTIFIC COMPANY BEHIND A2P2

Gulsine is a specialist materials-science company building the infrastructure for mechanism-driven product-lifetime decisions. Its core asset is A2P2: a patented framework and protected platform for determining material-specific activation behaviour, acceleration factors and study designs.

DR NAZLI GULSINE OZDEMIR CEng FIMMM

Founder and scientific lead. Dr Ozdemir has more than fifteen years of experience in polymer ageing, medical-device materials and product-lifetime assessment. She leads ASTM work relating to accelerated ageing and experimental Q₁₀ determination and contributes as a UK expert within ISO medical-device lifecycle work.

Her work connects first-principles materials science with the practical demands of R&D, quality systems, regulatory submissions and commercial product release.

WHAT GULSINE BUILDS

A2P2 is designed to become an internal enterprise capability—not a dependency on repeated one-off consulting. Organisations license the framework, establish a foundational programme around a lead product, transfer the methods into their laboratories and build a governed knowledge base across their portfolio.

IP PORTFOLIO

UK Patent GB2404188.1 granted. European application EP4621674 A1 published. Further UK and US applications pending.

ENTERPRISE ENQUIRIES

nazli@gulsineltd.com